文献

J-GLOBAL ID：201802234211553224   整理番号：18A1764387

末梢動脈疾患患者における線維芽細胞増殖因子-21の低血漿中濃度

Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease

著者 (12件)： Miyazaki Yoshichika (Department of Cardiology, National Hospital Organization Tokyo Medical Center) ,  Saita Emi (Endowed Research Department “Food for Health”, Ochanomizu University) ,  Kishimoto Yoshimi (Endowed Research Department “Food for Health”, Ochanomizu University) ,  Ibe Susumu (Department of Cardiology, National Hospital Organization Tokyo Medical Center) ,  Seki Toshiki (Department of Cardiology, National Hospital Organization Tokyo Medical Center) ,  Miura Kotaro (Department of Cardiology, National Hospital Organization Tokyo Medical Center) ,  Suzuki-Sugihara Norie (Graduate School of Humanities and Sciences, Ochanomizu University) ,  Ikegami Yukinori (Department of Cardiology, National Hospital Organization Tokyo Medical Center) ,  Ohmori Reiko (Faculty of Regional Design, Utsunomiya University) ,  Kondo Kazuo (Endowed Research Department “Food for Health”, Ochanomizu University) ,  Kondo Kazuo (Institute of Life Innovation Studies, Toyo University) ,  Momiyama Yukihiko (Department of Cardiology, National Hospital Organization Tokyo Medical Center)
資料名： Journal of Atherosclerosis and Thrombosis (Web)  (Journal of Atherosclerosis and Thrombosis (Web))
巻： 25  号： 9  ページ： 821-828(J-STAGE)  発行年： 2018年 
JST資料番号： U0153A  ISSN： 1880-3873  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ・目的:線維芽細胞成長因子-21(FGF-21)は糖脂質代謝...

シソーラス用語： ヒト ,...
準シソーラス用語： 冠動脈造影法 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1764387&from=J-GLOBAL&jstjournalNo=U0153A") }}

著者キーワード (3件)： 冠動脈疾患 ,  FGF-21 ,  末梢動脈疾患

分類 (2件)： 循環系の診断  (GJ02000V) ,  疫学  (GB03000E)

引用文献 (27件)：

• 1) Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB: FGF-21 as a novel metabolic regulator. J Clin Invest, 2005; 115: 1627-1635
• 2) Li H, Zhang J, Jia W: Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology. Front Med, 2013; 7: 25-30
• 3) Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ: The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology, 2007; 148: 774-781
• 4) Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A: Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes, 2008; 57: 1246-1253
• 5) Chen C, Cheung BM, Tso AW, Wang Y, Law LS, Ong KL, Wat NM, Xu A, Lam KS: High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects. Diabetes Care, 2011; 34: 2113-2115

タイトルに関連する用語 (4件)： 末梢動脈疾患 ,  患者 ,  線維芽細胞増殖因子 ,  血漿中濃度